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STUDY ON THE CONCENTRATION OF CEFMINOX SODIUM 
IN SERUM AND PROSTATIC TISSUE 
Isoji Sasagawa 
From the Department of Urology, Saiseikai Fukushima General Hospital 
The concentration of cefminox sodium (CMNX) in serum and prostatic tissue was determined 
in 25 patients with benign prostatic hypertrophy. One gram of CMNX was intravenously adminis-
tered prior to transurethral prostatectomy. Blood and prostatic tissue were obtained I hour after 
the administration of CMNX. The concentration of CMNX was 69.17±17.47 pg/ml (mean±SD) 
in serum and 5.33±2.33 pg/g (mean±SD) in the prostatic tissue. The ratio of the prostatic tissue 
concentration/serum concentration was 8.18±4.45% (mean ±SD). There was no correlation between 
serum and prostatic tissue level of CMNX. 
(Acta Urol. Jpn. 36: 737-739, 1990) 
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Fig． 1， Correlation between prostatic tissue
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